Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Am J Surg Pathol. 2012 Mar;36(3):351–359. doi: 10.1097/PAS.0b013e318236c312

Fig. 5.

Fig. 5

Prox1 in mesenchymal and epithelial neoplasms. A. Biphasic synovial sarcoma epithelium is positive. B. Prox1 labeling in paraganglioma cells. C. Cholangio-carcinoma with strong Prox1-immunoreactivity. D. Nuclear Prox1 positivity in small cell carcinoma of the lung.